1.42

2.74% -0.04

Pre-market: 1.46 0.04 +2.82%

Veraxa Biotech Ag (VRXA)

Overview News Price History Discussions Forecast

Veraxa Biotech Ag stock is traded at $1.42, with a volume of 49,064. It is down -2.74% in the last 24 hours and down -27.18% over the past month. Veraxa Biotech Holding AG focus on antibody therapies in medicine. The Company is an oncology-focused biotechnology Company with a clinical program in acute myeloid leukemia and two proprietary platform technologies that enable the development of new generations of antibody drug conjugates (ADC's) and T cell engagers. The Company operates in one reportable segment, focused on the research and development of products for the aging population.

Previous Close:

$1.46

Open:

$1.45

24h Volume:

49,064

Relative Volume:

0.09

Market Cap:

$200.80M

Revenue:

Net Income/Loss:

P/E Ratio:

EPS:

Net Cash Flow:

1W Performance:

-12.88%

1M Performance:

-27.18%

6M Performance:

+0.00%

1Y Performance:

+0.00%

1-Day Range:

$1.42

$1.52

1-Week Range:

$1.42

$1.6993

52-Week Range:

$1.27

$26.01

Veraxa Biotech Ag Stock (VRXA) Company Profile

Name

Veraxa Biotech Ag

Sector

Healthcare (1069)

Industry

Biotechnology (596)

Phone

Address

Employee

Twitter

Next Earnings Date

null

Latest SEC Filings

VRXA's Discussions on Twitter

Compare VRXA vs VRTX, REGN, MRNA, ARGX, ONC

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
VRXA Veraxa Biotech Ag	1.42	233.32M	0	0	0	0.00
VRTX Vertex Pharmaceuticals Inc	510.72	130.64B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	798.17	80.46B	14.92B	4.42B	3.79B	41.04
MRNA Moderna Inc	172.94	57.48B	2.23B	-3.19B	-1.60B	-8.1462
ARGX Argen X Se Adr	988.20	61.58B	4.16B	1.29B	734.26M	19.58
ONC Beone Medicines Ltd Adr	365.67	39.20B	5.76B	514.49M	1.10B	4.4813

Veraxa Biotech Ag Stock (VRXA) Latest News

Sep 13, 2026

Veraxa Biotech (VRXA) Insider Trading Activity 2026 - marketbeat.com

Sep 13, 2026

Sep 12, 2026

Veraxa Biotech AG Stock Price: VRXA Stock Chart, Market Cap & News Today - CoinGecko

Sep 12, 2026

Sep 10, 2026

VERAXA Biotech Appoints Dr. Christoph Erkel as CSO to Steer BiTAC® Toward Clinical Trials - citybuzz -

Sep 10, 2026

Veraxa Biotech (VRXA) Stock Price, News & Analysis - Stock Titan

Sep 10, 2026

Sep 09, 2026

VERAXA Biotech Designates Raju Willener as CFO - Yahoo Finance

Sep 09, 2026

VERAXA Biotech (NASDAQ: VRXA) Appoints Raju Willener As Chief Financial Officer - Menafn

Sep 09, 2026

Sep 08, 2026

Veraxa Biotech AG (NASDAQ: VRXA) Names Raju Willener as CFO Following De-SPAC Completion - Kalkine Media

Sep 08, 2026

symbol__ Stock Quote Price and Forecast - CNN

Sep 08, 2026

VERAXA Biotech (VRXA) Appoints Raju Willener as Chief Financial Officer - Yahoo Finance

Sep 08, 2026

VERAXA Biotech (NASDAQ: VRXA) Appoints Raju Willener as Chief Financial Officer - TradingView

Sep 08, 2026

Sep 06, 2026

VERAXA Biotech Appoints Veteran Finance Executive Raju Willener as CFO to Drive Capital Strategy and Oncology Pipeline Growth - citybuzz -

Sep 04, 2026